| Literature DB >> 7299844 |
Abstract
The level of binding of a labeled acetylcholine muscarinic antagonist (quinuclidinyl benzilate) to different cerebral membranes has been measured. Of the regions examined, circadian rhythmicity of binding could only be detected significantly in the hippocampus and the hypothalamus and not in the cerebral cortex, striatum, or cerebellum.Entities:
Mesh:
Substances:
Year: 1981 PMID: 7299844 DOI: 10.1002/jnr.490060306
Source DB: PubMed Journal: J Neurosci Res ISSN: 0360-4012 Impact factor: 4.164